共 50 条
Tea intake and cardiovascular disease: an umbrella review
被引:33
|作者:
Keller, Abby
[1
]
Wallace, Taylor C.
[2
]
机构:
[1] George Mason Univ, Dept Nutr & Food Studies, Fairfax, VA 22030 USA
[2] Think Hlth Grp, Washington, DC USA
关键词:
Tea;
cardiovascular diseases;
Camellia sinensis;
flavonoids;
heart diseases;
DENSITY-LIPOPROTEIN CHOLESTEROL;
DOSE-RESPONSE METAANALYSIS;
GREEN TEA;
BLOOD-PRESSURE;
BLACK TEA;
EPIGALLOCATECHIN GALLATE;
SYSTEMATIC REVIEWS;
METABOLIC SYNDROME;
LIPID PROFILE;
CONSUMPTION;
D O I:
10.1080/07853890.2021.1933164
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Brewed tea (Camellia sinensis) is a major dietary source of flavonoids, in particular flavan-3-ols. Tea consumption has been suggested to be inversely associated with a decreased risk of cardiovascular disease (CVD). Several biological mechanisms support the inverse relationship between tea flavonoid intake and CVD risk. Given the recent accumulating evidence from various systematic reviews regarding the role of tea as a beverage in reducing CVD risk and severity, we conducted an umbrella review to describe and critically evaluate the totality of evidence to date. We searched the PubMed, Web of Science, Cochrane Database of Systematic Reviews, and BIOSIS databases for systematic reviews published between January 1, 2010 and February 22, 2020 reporting relationships between tea (C. sinensis) consumption and CVD mortality, CVD diagnosis or incidence, CVD events, stroke events, blood pressure, endothelial function, blood lipids and triglycerides, and inflammatory markers. Herein, we describe results from 23 included systematic reviews. Consistently consuming 2 cups of unsweet tea per day offers the right levels of flavonoids to potentially decrease CVD risk and its progression. This is supported by the consistency between a recent high-quality systematic review and dose-response meta-analyses of population-based studies demonstrating beneficial effects of consumption on CVD mortality, CVD events and stroke events and medium- to high-quality systematic reviews of intervention studies that further elucidate potential benefits on both validated (i.e., SBP, DBP, total cholesterol, and LDL-cholesterol) and emerging risk biomarkers of CVD (TNF-alpha and IL-6). On the basis of this umbrella review, the consumption of tea as a beverage did not seem to be harmful to health; therefore, the benefits of moderate consumption likely outweigh risk. Future large, clinical intervention studies will provide better mechanistic insight with the ability to confirm the outcome effects shown across observational studies.
引用
收藏
页码:929 / 944
页数:16
相关论文